Form4insider filings, from the source

SEC Form 4 · accession 0001179110-16-025380

AMAG PHARMACEUTICALS INC. · AMAG

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
May 19, 2016
Accepted (ET)
May 23, 2016 · 5:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000792977

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2May 19, 2016A4,768—A12,990D
Common StockF3holding———4,400ISee Footnote 3

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F2,F4$18.35May 19, 2016A12,787A—May 19, 2026Common Stock12,78712,787D

Explanation of responses